<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03301961</url>
  </required_header>
  <id_info>
    <org_study_id>PTHO1701</org_study_id>
    <nct_id>NCT03301961</nct_id>
  </id_info>
  <brief_title>Multiplex Analysis of Circulating Tumor DNA</brief_title>
  <official_title>The Clinical Applications of Multiplex Analysis of Circulating Tumor DNA Biomarkers in Lung Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer is the leading cause of cancer-related death in China. This study will explore
      the applications of multiplex analysis of circulating tumor DNA biomarkers for diagnosis and
      surveillance of lung cancer patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-small cell lung cancer (NSCLC) constitutes about 85% of all newly diagnosed cases of lung
      cancer and continues to be the leading cause of cancer-related deaths worldwide.Early
      diagnosis and monitoring tumor recurrence after surgery are still far from satisfying.

      Circulating tumor DNA(ctDNA) detection has been proved to be feasible in early stage NSCLC in
      previous studies.Both genomic mutation and methylation a promising biomarker.Therefore,this
      study will perform multiplex detection of ctDNA,analysing mutations, methylation and other
      biomarkers,focusing on the early diagnosis and postoperative surveillance for NSCLC patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The sensitivity and specificity of multiplex peripheral blood ctDNA biomarkers in the diagnosis of non-small cell lung cancer</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparing the sensitivity and specificity of each peripheral blood biomarkers for the diagnosis of non-small cell lung cancer</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The sensitivity and specificity of multiplex peripheral blood ctDNA biomarkers for tumor relapse detection</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lead time of tumor relapse detection by multiplex ctDNA biomarkers than radiographic approaches</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Carcinoma</condition>
  <condition>Non-small-cell Lung Cancer</condition>
  <condition>Lung Neoplasm</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      A series of lung cancer patients plasma before and after surgery
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patient are found nodules in pulmonary and prepare for surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sign informed consent and consent to participate in this study;

          2. Found small nodules in pulmonary by CT and prepare for surgery;

        Exclusion Criteria:

          1. Malignant tumor history within the past 5 years;

          2. Receiving chemotherapy, radiotherapy or targeted therapy before surgery;

          3. No matching tissue or blood samplesUnqualified blood samples

          4. Lesion is pure ground glass opacity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kezhong Chen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kezhong Chen, MD</last_name>
    <phone>（+86）13488752289</phone>
    <email>mdkzchen@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heng Zhao, MD</last_name>
    <phone>（+86）13683139396</phone>
    <email>zhaohengzhaoheng@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kezhong Chen, M.D.</last_name>
      <phone>+8613488752289</phone>
      <email>mdkzchen@163.com</email>
    </contact>
    <investigator>
      <last_name>Jun Wang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2017</study_first_submitted>
  <study_first_submitted_qc>September 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2017</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Jun Wang</investigator_full_name>
    <investigator_title>Chief，Thoracic Surgery Service</investigator_title>
  </responsible_party>
  <keyword>Circulating Tumor DNA</keyword>
  <keyword>Early diagnosis</keyword>
  <keyword>Surveillance</keyword>
  <keyword>Methylation</keyword>
  <keyword>Somatic mutation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

